Sight Sciences, Inc. 8-K

What Happened
Sight Sciences, Inc. (SGHT) filed an 8-K on June 5, 2026 reporting the results of its annual meeting of stockholders held June 4, 2026. At the close of business on the April 8, 2026 record date, 54,403,542 shares of common stock were outstanding; 41,456,258 shares (≈76.2%) were present virtually or by proxy. Gerhard Burbach and Staffan Encrantz were elected as Class II directors, and Deloitte & Touche LLP was ratified as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

Key Details

• Record date: April 8, 2026; Outstanding common shares: 54,403,542.
• Shares present/voted at meeting: 41,456,258 (≈76.2% of outstanding).
• Director election votes:
  • Gerhard Burbach — For: 24,961,185; Withheld: 2,877,580; Broker non‑votes: 13,617,493.
  • Staffan Encrantz — For: 23,901,624; Withheld: 3,937,141; Broker non‑votes: 13,617,493.
• Auditor ratification votes: For: 41,059,471; Against: 7,892; Abstain: 388,895.
• No other matters were voted on at the meeting.

Why It Matters
The vote finalizes the Class II board composition through the next cycle (directors generally serve until the 2029 annual meeting) and confirms Deloitte & Touche LLP as the company’s auditor for 2026, providing continuity in governance and financial oversight. The vote totals and sizable broker non‑vote amount for the director elections are factual indicators of how shares controlled by brokers were treated in the proxy vote; investors can refer to these results and the company’s proxy statement for more context on director profiles and governance details.